Portal de Periódicos da CAPES

Pathobiology of chemical hepatocarcinogenesis: Recent progress and perspectives. Part I. Cytomorphological changes and cell proliferation

1990; Wiley; Volume: 5; Issue: 2 Linguagem: Inglês

10.1111/j.1440-1746.1990.tb01820.x

1440-1746

Peter Bannasch,

Genomics, phytochemicals, and oxidative stress

Journal of Gastroenterology and HepatologyVolume 5, Issue 2 p. 149-159 Pathobiology of chemical hepatocarcinogenesis: Recent progress and perspectives. Part I. Cytomorphological changes and cell proliferation PETER BANNASCH, Corresponding Author PETER BANNASCH Abteilüng für Cytopathologie, Deutsches Krebsforschungszentrum, Heidelberg, Federal Republic of GermanyProf. Dr P. Bannasch, Abteilüng für Cytopathologie, Deutsches Krebsforschungszentrum, D 6900 Heidelberg, Federal Republic of Germany.Search for more papers by this author PETER BANNASCH, Corresponding Author PETER BANNASCH Abteilüng für Cytopathologie, Deutsches Krebsforschungszentrum, Heidelberg, Federal Republic of GermanyProf. Dr P. Bannasch, Abteilüng für Cytopathologie, Deutsches Krebsforschungszentrum, D 6900 Heidelberg, Federal Republic of Germany.Search for more papers by this author First published: March 1990 https://doi.org/10.1111/j.1440-1746.1990.tb01820.xCitations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Reference 1 Muñoz N. & Bosch X. Epidemiology of hepatocellular carcinoma. In: K. Okuda & K.G. Ishak, eds, Neoplasms of the Liver. Springer-Verlag, Tokyo . 1987; 3–19. 2 Pitot H.C. Hepatic neoplasia: Chemical induction. In: J.M. Arias, W.B. Jakoby, H. Popper, D. Schachter & D.A. Shafritz, eds, The Liver, 2nd edn. Biology and Pathobiology. Raven Press, New York . 1988; 1125–46. 3 Beasley R.P., Hwang L.Y., Lin C.C. & Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; 2: 1129–33. 4 Kew M.C. Role of cirrhosis in hepatocarcinogenesis. In: P. Bannasch, D. Keppler & G. Weber, eds, Liver Cell Carcinoma. MTP Press, Lancaster . 1989; 35–43. 5 Melbye M., Skinhøj P., Nielsen N.H. et al. Virus-associated cancer in Greenland: Frequent hepatitis B virus infection but low primary hepatocellular carcinoma incidence. J. Natl Cancer Inst. 1984; 73: 1267–72. 6 Lin T.M., Tsu W.T. & Chen C.J. Mortality of hepatoma and cirrhosis of liver in Taiwan. Brit. J. Cancer 1986; 54: 969–76. 7 Okuda K., Fujimoto I., Hanai A. & Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 1987; 47: 4967–72. 8 Sakamoto M., Hirohashi S., Tsuda H. et al. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res. 1988; 48: 7294–7. 9 Tiollais P., Pourcel C. & Dejean A. The hepatitis B virus. Nature 1985; 317: 489–95. 10 Zur Hausen H. Intracellular surveillance of persisting viral infections. Lancet 1986; 2: 489–91. 11 Peers F., Bosch X., Kaldor J., Linsell A. & Pluijomen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int. J. Cancer 1987; 39: 545–53. 12 International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic: risks to humans. Overall Evaluations of Carcinogenicity: An updating of IARC Monographs Vols 1–42, Suppl. 7. International Agency for Research on Cancer, Lyon . 1987. 13 Goodman Z.D. Benign tumors of the liver. In: K. Okuda & K.G. Ishak, eds, Neoplasms of the Liver. Springer-Verlag, Tokyo . 1987; 105–25. 14 Bannasch P. & Zerban H. Modulation of hepatocellular phenotype and proliferation in liver cirrhosis. In: J.L. Boyer & L. Bianchi, eds, Liver Cirrhosis. MTP Press, Lancaster . 1987; 27–38. 15 Arakawa M., Kage M., Sugihara S., Nakashima T., Suenaga M. & Okuda K. Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Gastroenterology 1986; 91: 198–208. 16 Gerber M.A. Recent studies on the developing human hepatocellular carcinoma. Cancer Surv. 1986; 5: 741–63. 17 Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729–38. 18 Farber E. & Cameron R. The sequential analysis of cancer development. Adv. Cancer Res. 1980; 31: 125–226. 19 Moore M.A. & Kitagawa T. Hepatocarcinogenesis in the rat; the effect of the promoters and carcinogens in vivo and in vitro. Int. Rev. Cytol. 1986; 101: 125–73. 20 Bannasch P. Phenotypic cellular changes as indicators of stages during neoplastic development. In: O.H. Iversen, ed., Theories of Carcinagenesis. Hemisphere Publishing Corporation, Washington . 1988; 231–49. 21 Bannasch P. Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 1986; 7: 689–95. 22 Farber E. & Sarma D.S.R. Hepatocarcinogenesis: A dynamic cellular perspective. Lab. Invest. 1987; 56: 4–22. 23 Sato K. Glutathione S-transferases and hepatocarcinogenesis. Jpn. J. Cancer Res. (Gann) 1988; 79: 556–72. 24 Bannasch P. The cytoplasm of hepatocytes during carcinogenesis. Light and electron microscopic investigations of the nitrosomorpholine-intoxicated rat liver. Rec. Res. Cancer Res. 1968; 19: 1–100. 25 Goldsworthy T.L., Hanigan H.M. & Pitot H.C. Models of hepatocarcinogenesis in the rat — Contrasts and comparisons. CRC Crit. Rev. Toxicol. 1986; 17: 61–89. 26 Enzmann H. & Bannasch P. Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis 1987; 8: 1607–12. 27 Kitagawa T. Histochemical analysis of hyperplastic lesions and hepatomas of the liver of rats fed 2-fluorenylacetamide. Gann 1971; 62: 207–16. 28 Farber E. The biology of carcinogen-induced hepatocyte nodules and related liver lesions in the rat. Toxicol. Pathol. 1982; 10: 197–205. 29 Moore M.A., Hacker H.J. & Bannasch P. Phenotypic instability in focal and nodular lesions induced in a short term system in the rat liver. Carcinogenesis 1983; 4: 595–603. 30 Abe K., Kurata T., Shikata T. & Tennant B.C. Enzyme-altered liver cell foci in woodchucks infected with woodchuck hepatitis virus. Jpn. J. Cancer Res. (Gann) 1988; 79: 466–72. 31 Bannasch P., Hacker H.J., Klimek F. & Mayer D. Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Advan. Enzyme Regul. 1984; 22: 97–121. 32 Buchmann A., Kuhlmann W., Schwarz M. et al. Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferase B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis 1985; 6: 513–521. 33 Farber E. Hyperplastic liver nodules. Meth. Cancer Res. 1973; 7: 345–75. 34 Weinbren K. Precancerous states in the liver. In R.L. Carter, ed., Precancerous States. Oxford University Press, London . 1984; 254–77. 35 Edmondson H.A. Benign epithelial tumors and tumor-like lesions of the liver. In: K. Okuda & R.L. Peters, eds, Hepatocellular Carcinoma. Wiley, New York . 1976; 309–30. 36 Rabes H.M. Cell proliferation and hepatocarcinogenesis. In: M.B. Roberfroid & V. Preat, eds, Experimental Hepatocarcinogenesis. Plenum Press, New York . 1988; 121–32. 37 Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylaminofluorene and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res. 1956; 16: 142–8. 38 Sell S., Hunt J.M., Knoll B.J. & Dunsford H.A. Cellular events during hepatocarcinogenesis in rats and the question of premalignancy. Advan. Cancer Res. 1987; 48: 37–111. 39 Tatematsu M., Ho R.H., Kaku T., Ekem J.K. & Farber E. Studies on the proliferation and fate of oval cells in the liver of rats treated with 2-acetylaminofluorene and partial hepatectomy. Amer. J. Pathol. 1984; 114: 418–30. 40 Bannasch P. & Massner B. Histogenese und Cytogenese von Cholangiofibromen und Cholangiocarcinomen bei Nitrosomorpholinvergifteten Ratten. Z. Krebsforsch 1976; 87: 239–55. 41 Tatematsu M., Kaku T., Medline A. & Farber E. Intestinal metaplasia as a common option of oval cells in relation to cholangiofibrosis in liver of rats exposed to 2-acetylaminofluorene. Lab. Invest. 1985; 52: 354–62. 42 Moore M.A., Fukushima S., Ichihara A., Sato K. & Ito N. Intestinal metaplasia and altered enzyme expression in propylnitrosamine-induced Syrian hamster cholangiocellular and gallbladder lesions. Virchows Arch. B (Cell Pathol.) 1986; 51: 29–38. 43 Makino Y., Yamamoto K. & Tsuji T. Three-dimensional arrangement of ductular structures formed by oval cells during hepatocarcinogenesis. Acta Med. Okayama 1988; 42: 143–50. 44 Bannasch P., Enzmann H., Hacker H.J., Weber E. & Zerban H. Comparative pathobiology of hepatic preneoplasia. In: P. Bannasch, D Keppler & G. Weber, eds, Liver Cell Carcinoma. MTP Press, Lancaster . 1989; 53–74. 45 Kunz W., Appel K.E., Rickart R., Schwarz M. & Stöckle G. Enhancement and inhibition of carcinogenic effectiveness of nitrosamines. In: H. Remmer, H.M. Bolt, P. Bannasch & H. Popper, eds, Primary Liver Tumours. MTP Press, Lancaster . 1978; 261–83. 46 Emmelot P. & Scherer E. The first relevant cell stage in rat liver carcinogenesis: a quantitative approach. Biochim. Biophys. Acta 1980; 605: 247–304. 47 Moore M.A., Mayer D. & Bannasch P. The dose-dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitroso-morpholine. Carcinogenesis 1982; 3: 1429–36. 48 Zerban H., Preussmann R. & Bannasch P. Dose-time relationship of the development of preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine. Carcinogenesis 1988; 9: 607–10. 49 Zerban H., Preussmann P. & Bannasch P. Quantitative morphometric comparison between the expression of two different ‘marker enzymes’ in preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine. Cancer Lett. 1988; 43: 99–104. 50 Weber E. Dosisabhängigkeit der Sequenz zellulärer Veränderungen bei der N-Nitrosomorpholin-induzierten Hepatokarzinogenese in der Ratte. Thesis, Technische Hochschüle, Darmstadt . 1988. 51 Scherer E. & Hoffmann M. Probable clonal genesis of cellular islands induced in rat liver by diethylnitrosamine. Eur. J. Cancer 1971; 7: 369–71. 52 Rabes H.M., Bücher T., Hartmann A., Linke I. & Dünnwald M. Clonal growth of carcinogen-induced enzyme-deficient preneoplastic cell populations in mouse liver. Cancer Res. 1982; 42: 3220–7. 53 Howell S., Wareham K.A. & Williams E.D. Clonal origin of mouse liver cell tumors. Amer. J. Path. 1985; 121: 426–32. 54 Tsuji, S., Ogawa K., Takasaka H., Sonoda T. & Mori M. Clonal origin of γ-glutamyl transpeptidase-positive hepatic lesions induced by initiation-promotion in ornithine carbamoyltransferase mosaic mice. Jpn. J. Cancer Res. 1988; 79: 148–51. 55 Weinberg W.C. & Iannaccone P.M. Clonality of preneoplastic liver lesions: Histological analysis in chimeric rats. J. Cell. Sci. 1988; 89: 423–31. 56 Willis R.A., Pathology of Tumors, 2nd edn. Butterworths, London . 1953. 57 Bannasch P., Zerban H. & Hacker H.J. Foci of altered hepatocytes, rat. In: T.C. Jones, U. Mohr & R.D. Hunt, eds, Monographs on Pathology of Laboratory Animals, Digestive System. Springer-Verlag, Berlin . 1985; 10–30. 58 Bannasch P. & Zerban H. Tumours of the liver. In: V.S. Turusov et al., eds, Pathology of Tumours in Laboratory Animals, 2nd edn. Tumours of the Liver in the Rat, 2nd edn. International Agency for Research on Cancer, Lyon . 1989; in press. 59 Hirota N. & Yokoyama T. Comparative study of abnormality in glycogen storing capacity and other histochemical phenotypic changes in carcinogen-induced hepatocellular preneoplastic lesions in rat. Acta Pathol. Jpn. 1985; 35: 1163–79. 60 Peraino C., Staffeldt E.F., Carnes B.A., Ludeman V.A., Blomquist J.A. & Vesselinovitch S.D. Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res. 1984; 44: 3340–7. 61 Peraino C., Carnes B.A., Stevens F.J. et al. Comparative developmental and phenotypic properties of altered hepatocyte foci and hepatic tumors in rats. Cancer Res. 1988; 48: 4171–8. 62 Weber E. & Bannasch P. Dose-dependence of preneoplastic lesion phenotype in N-nitroso-morpholine-induced hepatocarcinogenesis. Falk-Symposium No 51. Liver Cell Carcinoma. 1988; 43. 63 Zerban H., Rabes H.M. & Bannasch P. Sequential changes in growth kinetics and cellular phenotype during hepatocarcinogenesis. J. Cancer Res. Clin. Oncol. 1989; 329–34. 64 Bannasch P., Benner U., Enzmann H. & Hacker H.J. Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1. Carcinogenesis 1985; 6: 1641–8. 65 Schröter C., Parzefall W., Schröter H. & Schulte-Hermann R. Dose–response studies on the effects of α-, β-, and γ-hexachlorocyclohexane on putative preneoplastic foci, monooxygenases, and growth in rat liver. Cancer Res. 1987; 47: 80–8. 66 Bannasch P., Mayer D. & Hacker H.J. Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim. Biophys. Acta 1980; 605: 217–45. 67 Enzmann H. & Bannasch P. Morphometric study of alterations of extrafocal hepatocytes of rat liver treated with N-nitrosomorpholine. Virchows Arch. B (Cell Pathol.) 1987; 53: 218–26. 68 Weber E., Moore M.A. & Bannasch P. Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine. Carcinogenesis 1988; 9: 1049–54. 69 Weber E., Moore M.A. & Bannasch P. Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal lesion development in Sprague-Dawley rats by dehydro-epiandrosterone. Carcinogenesis 1988; 9: 1191–5. 70 Rabes H.M. Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogens. J. Cancer Res. Clin. Oncol. 1983; 106: 85–92. 71 Tanaka T., Mori H., Hirota N., Furuya K. & Williams G.M. Effect of DNA synthesis on induction of preneoplastic and neoplastic lesions in rat liver by a single dose of methylazooxymethanol acetate. Chem.-biol. Interactions 1986; 58: 13–27. 72 Scherer E., Hoffmann M., Emmelot P. & Friedrich-Freksa H. Quantitative study on foci of altered liver cells induced in the rat by a single dose of diethylnitrosamine and partial hepatectomy. J. Natl Cancer Inst. 1972; 49: 93–106. 73 Cayama E., Tsuda H., Sarma D.S.R. & Farber E. Initiation of chemical carcinogenesis requires cell proliferation. Nature (Lond.) 1978; 275: 60–2. 74 Pound A.W. & McGuire L.J. Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rats. Brit. J. Cancer 1978; 37: 585–94. 75 Ishikawa T., Takayama S. & Kitagawa T. Correlation between time of partial hepatectomy after a single treatment with diethylnitrosamine and induction of adenosinetriphosphatase-deficient islands in rat liver. Cancer Res. 1980; 40: 4261–4. 76 Columbano A., Rajalakshimi S. & Sarma D.S.R. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res. 1981; 41: 2079–83. 77 Rabes H.M., Müller L., Hartmann A., Kerler R. & Schuster C. Cell cycle-dependent initiation of adenosine triphosphatase-deficient populations in adult rat liver by a single dose of N-methyl-N-nitrosourea. Cancer Res. 1986; 46: 645–50. 78 Columbano A., Ledda-Columbano G.M., Lee G., Rajalakshimi S. & Sarma D.S.R. Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. Cancer Res. 1987; 47: 5557–9. 79 Bartsch H., Préat V., Aitio A., Cabral J.R.P. & Roberfroid M. Partial hepatectomy of rats ten weeks before carcinogen administration can enhance liver carcinogenesis: preliminary observations. Carcinogenesis 1988; 9: 2315–7. 80 Sorof S. & Custer R.P. Elevated expression and cell cycle deregulation of a mitosis-associated target polypeptide of a carcinogen in hyperplastic and malignant rat hepatocytes. Cancer Res. 1987; 47: 210–20. 81 Rotstein J., Sarma D.S.R. & Farber E. Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis. Cancer Res. 1986; 46: 2377–85. 82 Tatematsu M., Aoki T., Kagawa M., Mera Y. & Ito N. Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats. Carcinogenesis 1988; 9: 221–5. 83 Columbano A., Ledda-Columbano G.M., Rao P.M., Rajalakshimi S. & Sarma D.S.R. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells: A sequential study. Amer. J. Pathol. 1984; 116: 441–6. 84 Bursch W., Lauer B., Timmermann-Trosiener T., Barthel G., Schuppler J. & Schulte-Hermann R. Controlled cell death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 1984; 5: 453–8. 85 Enzmann H. & Bannasch P. Non-persisting early foci of altered hepatocytes induced in rats by N-nitrosomorpholine. J. Cancer Res. Clin. Oncol. 1988; 114: 30–4. 86 Schwarze P.E., Petterson E.O., Tolleshaug H. & Seglen P.O. Isolation of carcinogen-induced diploid rat hepatocytes by centrifugal elutriation. Cancer Res. 1986; 46: 4732–7. 87 Deleener A., Castelain P., Préat V., De Gerlache J., Alexandre H. & Kirsch-Volders M. Changes in nucleolar transcriptional activity and nuclear DNA content during the first step of rat hepatocarcinogenesis. Carcinogenesis 1987; 8: 195–201. 88 Styles J.A., Kelly M. & Elcombe E.R. A cytological comparison between regeneration, hyperplasia and early neoplasia in the rat liver. Carcinogenesis 1987; 8: 391–9. 89 Haesen S., Derijcke T., Deleener A. et al. The influence of phenobarbital and butylated hydroxytoluene on the ploidy rate in rat hepatocarcinogenesis. Carcinogenesis 1988; 9: 1755–61. 90 Saeter G., Schwarze P.E., Nesland J.M., Juul N., Pettersen E.O. & Seglen P.O. The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas. Carcinogenesis 1988; 9: 939–45. 91 Sargent L., Xu Y-H., Sattler G.L., Meisner L. & Pitot H.C. Ploidy and karyotype of hepatocytes isolated from enzyme-altered foci in two different protocols of multistage hepatocarcinogenesis in the rat. Carcinogenesis 1989; 10: 387–91. 92 Romagna F. & Zbinden G. Distribution of nuclear size and DNA content in serial liver biopsies of rats treated with N-nitrosomorpholine, phenobarbital and butylated hydroxytoluene. Exp. Cell Res. 1981; 49: 294–305. 93 Mori H., Tanaka T., Sugie S., Takahashi M. & Williams G.M. DNA content of liver cell nuclei of N-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci. J. Natl Cancer Inst. 1982; 69: 1277–82. 94 Digernes V. Chemical liver carcinogenesis: monitoring of the process by flow cytometric DNA measurements. Environ. Health Perspectives 1983; 50: 195–200. 95 Sarafoff M., Rabes H.M. & Dormer P. Correlations between ploidy and initiation probability determined by DNA cytophotometry in individual altered hepatic foci. Carcinogenesis 1986; 7: 1191–6. 96 Danielsen H.E., Steen H.B., Lindmo T. & Reith A. Ploidy distribution in experimental liver carcinogenesis in mice. Carcinogenesis 1988; 9: 59–63. 97 Gil, R., Callaghan R., Boix J., Pellin A. & Llombart-Bosch A. Morphometric and cytophotometric nuclear analysis of altered hepatocyte foci induced by N-nitrosomorpholine (NNM) and aflatoxin B1 (AFB1) in liver of Wistar rats. Virchows Arch. B (Cell Pathol.) 1988; 54: 341–9. 98 Klose U., Thierau D., Greim H. & Schwarz L.R. Centrifugal elutriation of hepatocytes from 2-acetylaminofluorene-treated rats and their characterization by flow cytometry. Carcinogenesis 1989; 10: 553–6. 99 Bannasch P. Die Cytologie der Hepatocarcinogenese. In: E. Grundmann, ed., Handbuch Allg. Pathol., VI/VII. Springer-Verlag, Berlin . 1975; 123–276. 100 Scherer E. Use of a programmable pocket calculator for the quantitation of precancerous foci. Carcinogenesis 1981; 2: 805–7. 101 Enzmann H., Edler L. & Bannasch P. Simple elementary method for the quantification of focal liver lesions induced by carcinogens. Carcinogenesis 1987; 8: 231–5. 102 Bannasch P. & Klinge O. Hepatozelluläre Glykogenose und Hepatobildung beim Menschen. Virchows Arch. A (Path. Anat.) 1971; 352: 157–64. 103 Balázs M. Licht- und elektronenmikroskopische Untersuchungen in einem Fall von primärem Leberkarzinom im Säuglingsalter. Zbl. Allg. Path. 1976; 120: 3–13. 104 Cain H. & Kraus B. Entwicklungsstörungen der Leber und Leberkarzinom im Säuglings- und Kindesalter. Deut. Med. Wochenschr. 1977; 102: 505–9. 105 Shapiro P., Ikeda R.M., Ruebner B.H., Connors M.H., Halsted C.C. & Abildgaard C.F. Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens. Amer. J. Dis. Child. 1977; 131: 1104–6. 106 Altmann H.W. Pathology of human liver tumors. In: H. Remmer, H.M. Bolt, P. Bannasch & H. Popper, eds, Primary Liver Tumors. MTP Press, Lancaster . 1978; 53–71. 107 Heine W.D. Experimentelle und menschliche hepatozelluläre Lebertumoren und ihre Vorstufen — histologische, enzymhistochemische und zellkinetische Charakteristika. In: O. Zelder, H.D. Röher, M. Fischer & J.C. Bode, eds, Experimentelle und klinische Hepatologie. F.K. Schattauer Verlag, Stuttgart . 1981; 13–24. 108 Fischer G., Hartmann H., Droese M., Schauer A. & Bock K.W. Histochemical and immunohistochemical detection of putative preneoplastic liver foci in woman after long-term use of oral contraceptives. Virchows Arch. B (Cell Pathol.) 1986; 50: 321–37. 109 Karhunen P.J. & Penttilä A. Preneoplastic lesions of human liver. Hepato-gastroenterol. 1987; 34: 10–5. 110 Schaff Z., Lapis K. & Henson D.E. Liver. In: D.E. Henson & J. Albores-Saavedra, eds, The Pathology of Incipient Neoplasia. W.B. Saunders, Philadelphia . 1986; 167–202. 111 Ohta G. & Nakanuma Y. Comparative study of three nodular lesions in cirrhosis. Adenomatoid hyperplasia, adenomatoid hyperplasia with intermediate lesion, and small hepatocellular carcinoma. In: K. Okuda & K.G. Ishak, eds, Neoplasms of the Liver. Springer-Verlag, Tokyo . 1987; 177–87. 112 Stocker J.T. & Ishak K.G. Hepatoblastoma. In: K. Okuda & K.G. Ishak, eds, Neoplasms of the Liver. Springer-Verlag, Tokyo . 1987; 127–36. 113 Wu P.C., Lai C.L., Lam K.C., Lok A.S.F. & Lin H.J. Clear cell carcinoma of liver. An ultrastructural study. Cancer 1983; 52: 504–7. 114 Audisio R., Bombelli L., Lombardi L. & Andreola S. A clinicopathologic study of clear-cell hepatocellular carcinoma. Tumori 1987; 73: 389–95. 115 Peters R.L. Pathology of hepatocellular carcinoma. In: K. Okuda & R.L. Peters, eds, Hepatocellular Carcinoma. Wiley and Sons, New York . 1976; 107–68. 116 Anthony P.P., Vogel C.L. & Barker L.F. Liver cell dysplasia: A premalignant condition. J. Clin. Pathol. 1973; 26: 217–23. Citing Literature Volume5, Issue2March 1990Pages 149-159 ReferencesRelatedInformation